Content by Advanced Dental Sleep Treatment Center. Thankfully, there is a treatment that’s effective, sustainable and ...

“Sleep apnea mouthguards (Oral Appliance Therapy) fit over the teeth and gums and keeps the airway patent resulting in improved sleep quality and other outcomes. They are FDA approved devices with ...

The Food and Drug Administration (FDA) has cleared the Vivos CARE (complete airway repositioning and/or expansion) oral appliances for the treatment of severe obstructive sleep apnea (OSA).

ORAL: Abstract 6336. Title: The Oral Agent AD109 Improves Objective and Subjective Outcomes in Obstructive Sleep Apnea Patients. Results from the MARIPOSA Study, a Randomized, Controlled Clinical ...

FDA-approved medical devices, including oral sleep apnea devices, such as positive airway pressure machines, sleep apnea surgery, and surgically implanted devices, such as Inspire; ...

ATLANTA -- An oral appliance for people with obstructive sleep apnea (OSA) was noninferior to continuous positive airway pressure (CPAP) for reducing 24-hour mean arterial blood pressure (BP) in ...

NEW YORK (Reuters Health), Aug 29 - Prefabricated thermoplastic oral appliances for mandibular advancement are not effective for treating mild sleep apnea, and clinicians should use custom-made ...

Vivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally in the company's shares before the bell.

Moderate-to-severe OSA was defined as 15 or more events per hour based on polysomnography or a home sleep apnea test within 1 year of surgery. In total, 13,657 adults (mean age 52.0 years; 54.9% male) ...

Apnimed announces positive topline results in the first landmark phase 3 clinical trial of AD109, an investigational once-daily oral pill for obstructive sleep apnea. News release. Apnimed.